EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders

Lauren M Schaefer, Gail A Kerver, Kelly C Allison, Bradley Kohoutek, Kristine J Steffen

Psychiatric Clinics of North America · 2026-03 · 49 (1) · 183-202

DOI: 10.1016/j.psc.2025.08.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Psychiatric Clinics of North America, 2026-03. Verfasst von Lauren M Schaefer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biobehavioral Research, Sanford Research, 4840 23rd Avenue S, Fargo, ND 58104, USA; Department of Psychiatry and Behavioral Science, Unive…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Feeding and Eating Disorders, Glucagon-Like Peptides, Binge-Eating Disorder. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide 1Feeding and Eating DisordersGlucagon-Like PeptidesBinge-Eating DisorderHumansSemaglutideTirzepatide

Stichwörter der Autor:innen

Binge eatingEating disordersGLP-1 agonist medicationsOzempicSemaglutideTirzepatideWegovyZepbound

Substanzen

Glucagon-Like Peptide 1Glucagon-Like PeptidesSemaglutideTirzepatide

Autor:innen und Institutionen

  • Center for Biobehavioral Research, Sanford Research, 4840 23rd Avenue S, Fargo, ND 58104, USA; Department of Psychiatry and Behavioral Science, University of North Dakota School of Medicine and Health Sciences. Electron…
  • Center for Biobehavioral Research, Sanford Research, 4840 23rd Avenue S, Fargo, ND 58104, USA; Department of Psychiatry and Behavioral Science, University of North Dakota School of Medicine and Health Sciences; Departme…
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 3029, Philadelphia, PA 19104-3309, USA.
  • Sanford Eating Disorders and Weight Management Center, 1717 S University Drive, Fargo, ND 58103, USA.
  • Center for Biobehavioral Research, Sanford Research, 4840 23rd Avenue S, Fargo, ND 58104, USA; Department of Pharmaceutical Sciences, North Dakota State University, 401 Albrecht Boulevard.

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • Novo Nordisk
  • Nordisk Atlantsamarbejde

Zitieren

APA

Schaefer, L. M., Kerver, G. A., Allison, K. C., Kohoutek, B., & Steffen, K. J. (2026). Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders. Psychiatric Clinics of North America, 49(1), 183-202. https://doi.org/10.1016/j.psc.2025.08.013

Vancouver

Schaefer LM, Kerver GA, Allison KC, Kohoutek B, Steffen KJ. Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders. Psychiatric Clinics of North America. 2026;49(1):183-202. doi:10.1016/j.psc.2025.08.013

BibTeX
@article{Schaefer2026,
  author = {Schaefer, Lauren M and Kerver, Gail A and Allison, Kelly C and Kohoutek, Bradley and Steffen, Kristine J},
  title = {Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders},
  journal = {Psychiatric Clinics of North America},
  year = {2026},
  volume = {49},
  number = {1},
  pages = {183--202},
  doi = {10.1016/j.psc.2025.08.013}
}
Kostenlos starten →